IP Library Granted Patent US 12,343,059
Granted Patent B2
US 12,343,059 · App. 17/096,043 · Granted Jul 1, 2025

Steam ablation device for treatment of menorrhagia

Inventors: Nikhil M. Murdeshwar (Maple Grove, MN); Thomas J. Holman (Princeton, MN)
Assignee: GYRUS ACMI, INC.
A61B18/04A61B2018/00095A61B2018/00101A61B2018/0022A61B2018/00559A61B2018/00577A61B2018/048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,059
App. No.
17/096,043
Granted
Jul 1, 2025
Kind
B2
Abstract

Disclosed herein is a vapor therapy device for producing intra-uterine tissue effects. The device can include a shaft, including a proximal portion and a distal portion, a fluid-expandable medium, near the distal portion of the shaft, a fluid-delivery conduit, extending between the proximal portion and the distal portion of the shaft, the fluid-delivery conduit comprising an outlet, near the distal portion of the shaft, for delivery of the fluid toward the medium, and an in vivo heat generator, near the distal portion of the shaft, to heat the fluid. A method of treating a patient for menorrhagia with the device can include introducing a medium, in a contracted state, into a patient, delivering a fluid toward the medium to expand the medium in vivo; generating heat in vivo on or near the medium to vaporize the fluid, and exposing a treatment site to the vaporized fluid.

Claims (26)

1. A vapor therapy device for producing intra-uterine tissue effect, for at least partial insertion into a patient, the device comprising:

a shaft, including a proximal portion and a distal portion;

an in vivo heat generator, near the distal portion of the shaft;

a fluid-expandable medium, near the distal portion of the shaft, and fully sheathing the in vivo heat generator, wherein the fluid-expandable medium comprises:

a pressure barrier layer encompassing an outlet of a fluid-delivery conduit;

a transport layer at least partially encompassing the pressure barrier layer; and

a tissue compliant layer at least partially surrounding the transport layer;

the fluid-delivery conduit, extending between the proximal portion and the distal portion of the shaft, the fluid-delivery conduit comprising the outlet, near the distal portion of the shaft, for providing fluid into the fluid-expandable medium, wherein the in vivo heat generator is configured to heat the fluid inside the fluid-expandable medium.

2. The device of claim 1 , wherein the in vivo heat generator is configured to vaporize the fluid in vivo.

3. The device of claim 1 , further comprising a valve in fluid communication with the fluid-delivery conduit, wherein the valve is configured to be user-controlled to control delivery of the fluid towards the medium via the valve.

4. The device of claim 1 , wherein the fluid-expandable medium is permeable to vapor.

5. The device of claim 1 , wherein the fluid-expandable medium has a porosity that increases when expanded.

6. The device of claim 1 , wherein the fluid-expandable medium comprises a balloon.

7. The device of claim 1 , wherein the fluid-expandable medium comprises a sponge.

8. The device of claim 1 , wherein the fluid-expandable medium comprises a relatively compressed state for insertion into the patient and is capable of expanding to a relatively expanded state.

9. The device of claim 8 , wherein the relatively compressed state comprises a diameter of less than about 6 mm for insertion.

10. The device of claim 8 , wherein the relatively expanded state comprises a diameter of about 6 cm to about 9 cm when expanded.

11. The device of claim 1 , wherein the transport layer has a porosity greater than the pressure barrier layer and wherein the tissue compliant layer has a porosity greater than the transport layer.

12. The device of claim 1 , wherein the transport layer has a higher heat capacity than the pressure barrier layer, and wherein the tissue compliant layer has a higher heat capacity than the transport layer.

13. The device of claim 1 , wherein the fluid-expandable medium includes a more thermally conductive region that is more distal to the outlet than a less thermally conductive region of the fluid-expandable medium.

14. The device of claim 1 , wherein the fluid-expandable medium includes reduced thermal conductivity portions configured to be located toward respective fallopian tubes in the patient.

15. The device of claim 1 , wherein the in vivo heat generator is configured to produce heat by passing a current through a resistor.

16. The device of claim 1 , wherein the outlet is located in the fluid-expandable medium.

17. The device of claim 1 , wherein the pressure barrier layer maintains a pressure threshold to prevent premature expansion of the fluid-expandable medium when the fluid is provided into the fluid-expandable medium.

18. The device of claim 1 , wherein the pressure layer, the transport layer, and the tissue compliant layer comprise a hardness measure indicating greater resistance to indentation.

19. The device of claim 18 , wherein the hardness measure increases from the pressure layer toward the tissue compliant layer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2020
From: MURDESHWAR, NIKHIL M.; HOLMAN, THOMAS
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 054347/0974 →
Continuity (2)
Provisional Application 62939820 · Nov 25, 2019
Related Publication 20210153921A1 · May 27, 2021
References Cited (25)
US 10154871B2 · Sharkey · 2018 [cited by examiner]
US 11457969B2 · Hoey · 2022 [cited by examiner]
US 11672584B2 · Hoey · 2023 [cited by examiner]
US 12042215B2 · Govari · 2024 [cited by examiner]
US 20020019627A1 · Maguire · 2002 [cited by examiner]
US 20020177846A1 · Mulier · 2002 [cited by examiner]
US 20040068306A1 · Shadduck · 2004 [cited by examiner]
US 20060135955A1 · Shadduck · 2006 [cited by examiner]
US 20060161233A1 · Barry · 2006 [cited by examiner]
US 20060224154A1 · Shadduck · 2006 [cited by examiner]
US 20080132826A1 · Shadduck · 2008 [cited by examiner]
US 20090054871A1 · Sharkey · 2009 [cited by examiner]
US 20090125010A1 · Sharkey · 2009 [cited by examiner]
US 20120245583A1 · Truckai · 2012 [cited by examiner]
US 20130030410A1 · Drasler et al. · 2013 [cited by applicant]
US 20150126990A1 · Sharma et al. · 2015 [cited by applicant]
US 20150335380A1 · Chee et al. · 2015 [cited by applicant]
US 20160051322A1 · Asirvatham · 2016 [cited by examiner]
CN 107847259 · 2018 [cited by applicant]
CN 112826582A · 2021 [cited by applicant]
EP 3244820A2 · 2017 [cited by applicant]
WO WO0000100A1 · 2000 [cited by applicant]
“European Application Serial No. 20209736.6, Extended European Search Report mailed Apr. 12, 2021”, 7 pgs. [cited by applicant]
“European Application Serial No. 20209736.6, Response Filed Oct. 18, 2021 to Extended European Search Report mailed Apr. 12, 2021”, 8 pgs. [cited by applicant]
“Chinese Application Serial No. 202011341437.3, Office Action mailed Feb. 27, 2025”, w English translation, 21 pgs. [cited by applicant]